Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Laboratory manual for yellow fever (2024)
- Management of a cholera epidemic - Practical guide for doctors, nurses, laboratory technicians, medical auxiliaries, water and sanitation specialists and logisticians (2023)
New Publications
- Multiple first-line therapies as part of the response to antimalarial drug resistance (2024)
- Considerations for wastewater and environmental surveillance for monkeypox virus: interim guidance, 25 November 2024 (2024)
- Mpox Testing Strategy - November 2024 (2024)
- Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection (March 2024) (2024)
- Framework for an Integrated Multisectoral Response to TB, HIV, STIS and Hepatitis in the WHO African Region 2021–2030 (2024)
Filter
546
Featured
Recommendations
94
New Publications
128
Language
Document type
No document type
239
Guidelines
138
Studies & Reports
39
Manuals
33
Strategic & Response Plan
27
Fact sheets
19
Online Courses
14
Training Material
13
Resource Platforms
9
Situation Updates
6
Infographics
6
Videos
3
Countries / Regions
Global
20
Latin America and the Carribbean
15
Africa
9
Ukraine
8
India
8
Middle East and North Africa
6
Russia
6
Congo, Democratic Republic of
5
Western and Central Europe
5
Brazil
5
Mozambique
4
South–East Asia Region
4
South Africa
4
Haiti
3
Germany
3
West and Central Africa
3
East and Southern Africa
3
Eastern Europe
3
Yemen
3
Kenya
2
Nigeria
2
Zimbabwe
2
Bangladesh
2
Zambia
2
Somalia
2
Nepal
1
Colombia
1
Sierra Leone
1
Chile
1
Syria
1
Senegal
1
Uzbekistan
1
Afghanistan
1
Malawi
1
Guinea
1
USA
1
Asia
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Argentina
1
Sri Lanka
1
Angola
1
Bhutan
1
Liberia
1
Ecuador
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
TB
111
HIV & STI
107
Vaccine-preventable Diseases
77
Malaria
77
MPOX - Monkeypox
50
Hepatitis
42
Diarrhoeal Disease/Cholera
37
Yellow Fever
24
Dermatology
20
Toolboxes
Adults
35
Drug resistant TB
29
MPOX - Monkeypox
27
MPOX - Monkeypox
25
Prevention & Control
15
Antiretroviral Treatment ART
15
Treatment Guidelines
13
MPOX -Monkeybox Prevention & Control
13
Clinical Aspects
12
Yellow Fever Prevention & Control
12
Treatment Guidelines HIV
11
Treatment & Prevention
10
Public Health
10
Cholera Prevention & Control
10
Children
10
Hepatitis
9
Detection & Diagnosis
9
Training
9
Cholera
9
Meningitis Prevention & Control
8
Yellow Fever
8
Opportunistic Infections
8
Co-Morbidities (except TB)
8
Diarrhoea
8
HIV testing & services
7
Clinical Guidelines
7
Outbreak Prevention & Control
6
ART Drug Resistance
6
Communication Material
6
HIV &TB
6
Women
6
TB
6
Surveillance
5
Online Courses
5
Handbooks & Manuals
5
Community Health Workers CHW
5
Prevention of mother-to-child transmission (PMTCT)
5
WASH
5
Policies & Strategies
4
Childhood TB
4
Infection Control
4
Training Material
4
Cholera
4
Guidelines & Manuals
4
Communication & Training
4
Meningitis & Encephalitis
4
Clinical Guidelines
3
Vaccination
3
Clinical Guidelines
3
Risk Communication & Community Engagement
3
Paediatrics
3
Immunization Guidelines
3
Others
3
General
3
Information & Education Material (IEC)
3
Capacity Building & Resource platforms
3
War Surgery & Wound Care
3
Prophylactic Treatment
3
TB/HIV Coinfection
3
Clinical Guidelines
3
WASH
3
HIV in Key Populations
3
Clinical Aspects, Treatment & Prevention
2
Influenza Prevention & Control
2
Pediatrics
2
Prevention Guidelines
2
Laboratory
2
TB
2
Training
2
Vaccination
2
HIV / AIDS
2
TB/HIV
2
Essential Medicines & Devices Lists
2
Emergency health kits
2
NTDs
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
Neurological Disorders
2
Context & Facts
2
Disaster Preparedness & Prevention
2
Clinical Guidelines
2
HIV and coinfection
2
Clinical Guidelines
1
Assessment & Studies
1
Surveillance
1
Laboratory Guidance
1
IPC
1
Information & Education Material (IEC)
1
Ebola Prevention & Control
1
Key Resources
1
HIV surveillance
1
Humanitarian Settings
1
Children
1
Assessment & Response
1
Policies
1
Transgender People
1
Online Resources
1
IEC Materials
1
Men who have sex with men (MSM)
1
HIV
1
Others
1
People who injecting Drugs
1
Research
1
TB & Other Vulnerable Populations
1
Ebola
1
PPE Personel Protective Equipment
1
International
1
Key Resources
1
Communication & Training
1
General
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Infection Control General
1
Global Impact: Socio-economic, health services, TB & HIV
1
HIV and COVID-19
1
COVID-19
1
Psychosocial Support
1
Vaccine Hesitancy & Myths
1
Health Promotion
1
Colombia
1
Brazil
1
Chile
1
Wound management
1
Essential Medicines
1
Rational use of Medicine
1
Online Courses
1
Ukraine
1
Prevention & Measures
1
Zoonoses
1
WASH Water Sanitation & Hygiene
1
Health Impact & Climate Change
1
Emergency health kits
1
Health Care In Conflict Settings
1
Chagas
1
NTDs General
1
Overview, Studies & Reports
1
Other NTDs
1
Access to treatment and laboratory
1
General Information
1
Online courses
1
Policies and guidelines
1
General
1
General Aspects
1
Assessment & Response
1
Malnutrition
1
Global Health Education
1
Nutrition
1
Latin America & the Carribean
1
HIV / AIDS
1
Resource Platforms
1
Testing Guidelines
1
Training
1
HIV service delivery
1
Western & Central Europe
1
Eastern Europe & Central Asia
1
Action Plans, Policies & Response
1
Kenya
1
Prisoners
1
Cyclones Idai & Kenneth
1
Vaccination
1
28 Sept. 2021
The focus of this fact sheet is on the four main causes of acute bacterial meningitis:
Neisseria meningitidis (meningococcus)
Streptococcus pneumoniae (pneumococcus)
Haemophilus influenzae
Streptococcus agalactiae (group B streptococcus)
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
7 June 2022. To treat complications associated with measles: severe complications with module 1 (50 cases) and mild complications with module 8 (20 cases).
The new measles kit 2021 is designed to prepare for and support the treatment of non-severe and severe measles cases during outbreaks. The kit ...
A World of Healthy People Who are Protected from Vaccine-Preventable Disease, Disability, and Death. Progress toward that vision is structured around five capacity building goals, and implemented using four guiding principles, to achieve health impact objectives.
In 2016 WHO introduced the Cholera Kits. These kits replace the Interagency Diarrhoeal Disease Kit (IDDK) which had been used for many years. The Cholera Kit is designed to be flexible and adaptable for preparedness and outbreak response in different contexts. The overall Cholera Kit is made up of a...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
La meningitis es una enfermedad mortal y debilitante; golpea rápidamente, conlleva graves consecuencias sanitarias, económicas y sociales, y afecta a personas de todas las edades y en todos los países del mundo. La meningitis bacteriana puede provocar epidemias, ocasionar la muerte en 24 horas y ...
Defeating meningitis by 2030: a global road map
Defeating meningitis by 2030: a roadmap
Estimated number of pregnant women, number with access to at least four antenatal care visits, and those delivering in hospital settings in the Americas, 2019...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
